Sex Differences in Effectiveness of Extended-Release Stimulant Medication among Adolescents with Attention-Deficit/Hyperactivity Disorder

被引:20
|
作者
Mikami, Amori Yee [1 ]
Cox, Daniel J. [2 ]
Davis, Margaret T. [2 ]
Wilson, H. Kent [3 ]
Merkel, R. Lawrence [2 ]
Burket, Roger [2 ]
机构
[1] Univ Virginia, Dept Psychol, Charlottesville, VA 22904 USA
[2] Univ Virginia, Dept Psychiat Med, Behav Med Ctr, Charlottesville, VA 22908 USA
[3] Univ Virginia, Curry Sch Educ, Charlottesville, VA 22904 USA
关键词
ADHD; Adolescents; Girls; Stimulant medication; Extended-release; DEFICIT-HYPERACTIVITY DISORDER; CHILDREN; METHYLPHENIDATE; ADHD; GIRLS; PHARMACOKINETICS; PERFORMANCE; GENDER; PHARMACOTHERAPY; INHIBITION;
D O I
10.1007/s10880-009-9165-8
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
This study examined whether adolescent females with attention-deficit/hyperactivity disorder (ADHD) are differentially responsive than their male counterparts to extended-release stimulant medications. This investigation may bear special importance for an adolescent (as opposed to child) population, because hormonal and metabolism differences between sexes are most likely to emerge at this time. Male (n = 19) and female (n = 16) adolescents, ages 16-19 with ADHD, participated in a randomized, double-blind crossover study evaluating the effectiveness of osmotic-release methylphenidate, extended release amphetamine salts, placebo, and routine limited medication regimen. Medication efficacy was evaluated using ADHD symptom ratings from adolescent self-report and parent report, along with objective measures of inattention and hyperactivity/impulsivity during driving performance and neuropsychological tasks. Males and females were largely equivalent in impairment, and medication was similarly effective in reducing symptoms. No interactions were found between sex and medication on any measure of effectiveness or side effects. This finding suggests that the efficacy and tolerability of extended-release stimulant medications is equivalent for male and female adolescents with ADHD.
引用
收藏
页码:233 / 242
页数:10
相关论文
共 50 条
  • [41] PERSISTENCE OF STIMULANT TREATMENT IN CHILDREN AND ADOLESCENTS WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER
    Palli, S. R.
    Aparasu, R. R.
    Chen, H.
    Sherer, J. T.
    VALUE IN HEALTH, 2011, 14 (03) : A200 - A200
  • [42] Cost-Effectiveness of Extended-Release Methylphenidate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder Sub-Optimally Treated with Immediate Release Methylphenidate
    van der Schans, Jurjen
    Kotsopoulos, Nikos
    Hoekstra, Pieter J.
    Hak, Eelko
    Postma, Maarten J.
    PLOS ONE, 2015, 10 (05):
  • [43] Effectiveness of neurofeedback versus medication for attention-deficit/hyperactivity disorder
    Sudnawa, Khemika Khemakanok
    Chirdkiatgumchai, Vilawan
    Ruangdaraganon, Nichara
    Khongkhatithum, Chaiyos
    Udomsubpayakul, Umaporn
    Jirayucharoensak, Suwicha
    Israsena, Pasin
    PEDIATRICS INTERNATIONAL, 2018, 60 (09) : 828 - 834
  • [44] Comparison of Fidgeting in Adolescents with Attention-Deficit/Hyperactivity Disorder Between Before and After Stimulant Medication Intake
    Sydenstricker, Shelby
    Moore, Alexandra
    Nagao, Kyoko
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2023, 33 (04) : 143 - 148
  • [45] Response to Guanfacine Extended Release in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD)
    Turnbow, John
    Kollins, Scott
    Lopez, Frank
    Lyne, Andrew
    Youcha, Sharon
    Rubin, Jonathan
    BIOLOGICAL PSYCHIATRY, 2010, 67 (09) : 218S - 218S
  • [46] Guanfacine Extended Release: A Novel Treatment for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
    Faraone, Stephen V.
    McBurnett, Keith
    Sallee, Floyd R.
    Steeber, Jennifer
    Lopez, Frank A.
    CLINICAL THERAPEUTICS, 2013, 35 (11) : 1778 - 1793
  • [47] Sex differences in neuropsychological functioning among children with attention-deficit/hyperactivity disorder
    Dolores Munoz-Suazo, Maria
    Navarro-Munoz, Jesus
    Diaz-Roman, Amparo
    Maria Porcel-Galvez, Ana
    Gil-Garcia, Eugenia
    PSYCHIATRY RESEARCH, 2019, 278 : 289 - 293
  • [48] Predictors of Stimulant Medication Continuity in Children with Attention-Deficit/Hyperactivity Disorder (ADHD)
    Kamimura-Nishimura, Kelly
    Brinkman, William
    Epstein, Jeffery
    Zhang, Yin
    Altaye, Mekibib
    Froehlich, Tanya
    JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 2020, 41 (02): : S25 - S25
  • [49] Selective Inhibition in Children with Attention-Deficit Hyperactivity Disorder Off and On Stimulant Medication
    Anne-Claude Bedard
    Abel Ickowicz
    Gordon D. Logan
    Sheilah Hogg-Johnson
    Russell Schachar
    Rosemary Tannock
    Journal of Abnormal Child Psychology, 2003, 31 : 315 - 327
  • [50] Evaluating the likelihood to be helped or harmed after treatment with viloxazine extended-release in children and adolescents with attention-deficit/hyperactivity disorder
    Nasser, Azmi
    Kosheleff, Alisa R.
    Hull, Joseph T.
    Liranso, Tesfaye
    Qin, Peibing
    Busse, Gregory D.
    Fava, Maurizio
    Maletic, Vladimir
    Rubin, Jonathan
    Lopez, Frank
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (08)